Eduovisual
Cardiovascular
Pericardial effusion and cardiac tamponade: pericardiocentesis decision
— Rapid (hemopericardium from trauma, aortic dissection, post-PCI perforation, post-MI free wall rupture): as little as 100–200 mL causes shock.
— Slow (malignancy, uremia, hypothyroidism, idiopathic): pericardium stretches, can hold >1–2 L before decompensation.
— Unexplained hypotension or PEA arrest in a patient with chest trauma, recent cardiac procedure, anticoagulation, or known malignancy.
— Dyspnea + elevated JVP + clear lungs (think tamponade or RV infarct, not LV failure).
— Pulsus paradoxus >10 mmHg on a routine BP cuff.
— New cardiomegaly on CXR with globular ("water-bottle") silhouette.
— Malignancy (lung, breast, lymphoma, melanoma) — most common cause of large effusion in US adults.
— Infectious: viral (most), TB (immigrants/HIV), purulent bacterial.
— Autoimmune: SLE, RA, scleroderma, Dressler syndrome.
— Metabolic: uremia (HD patients), severe hypothyroidism (myxedema).
— Iatrogenic/procedural: post-PCI, post-pacemaker lead, post-cardiac surgery, post-ablation.
— Traumatic/aortic dissection — surgical, not percutaneous, drainage.
Board pearl: A hypotensive patient who became suddenly unstable during or after a cardiac catheterization or pacemaker placement has tamponade until proven otherwise — get a bedside echo immediately, do not wait for the formal study. The decision to drain is clinical + echocardiographic, not based on effusion size alone.
— Abrupt dyspnea, chest pressure, presyncope, then obstructive shock.
— Patient appears agitated, cold, mottled, tachycardic, hypotensive.
— Often progresses to PEA arrest within minutes.
— Progressive dyspnea on exertion over days–weeks, orthopnea, fatigue.
— Cough, dysphagia, hiccups (phrenic/esophageal compression from large effusion).
— Right-sided congestion: peripheral edema, abdominal fullness, early satiety, hepatic congestion.
— Often misdiagnosed as CHF or pneumonia initially.
— Recent procedures: PCI, pacemaker, EP ablation, cardiac surgery, central line.
— Anticoagulation/antiplatelet use — especially in elderly with chest trauma or post-MI.
— Cancer history + recent chemotherapy/radiation to thorax.
— Renal failure on dialysis (uremic pericarditis) — was last HD session missed?
— TB exposure, HIV status, recent immigration.
— Chest pain syndrome preceding presentation: viral prodrome (acute pericarditis → effusion); tearing pain radiating to back (dissection — DO NOT drain percutaneously); recent transmural MI (free wall rupture, days 3–7).
— Symptoms of hypothyroidism: weight gain, cold intolerance, constipation, slow reflexes.
— Autoimmune symptoms: rash, arthritis, serositis, Raynaud.
Key distinction: Patients with slow, large effusions can look surprisingly well at rest but decompensate rapidly with even small volume losses (vomiting, diuretics, sedation for intubation). Always ask "has anyone given them a diuretic?" — that's a classic stem trigger for iatrogenic worsening.
— Hypotension
— Muffled/distant heart sounds
— Elevated JVP (with absent y descent — diastolic filling impaired throughout diastole).
— Measurement technique: inflate cuff above SBP, deflate slowly; note pressure at which Korotkoff sounds heard only in expiration, then where heard throughout cycle; difference = pulsus.
— Mechanism: inspiratory RV filling pushes septum into LV in constrained pericardium → ↓LV stroke volume.
— False negatives: severe LV dysfunction, ASD, aortic regurgitation, RV hypertrophy, positive-pressure ventilation, regional tamponade post-op.
— False positives: severe asthma/COPD, massive PE, obesity, hypovolemic shock.
— Sinus tachycardia (compensatory; loss of this in beta-blocked or terminal patients is ominous).
— Cool extremities, narrow pulse pressure.
— Kussmaul sign (rise in JVP with inspiration) — more typical of constrictive pericarditis but can occur in effusive-constrictive disease.
— Ewart sign — dullness and bronchial breath sounds below left scapula from compressive atelectasis.
— Pericardial friction rub may be present with effusion (does not exclude it).
— Continuous BP, pulse-ox plethysmography variation (>13% suggestive surrogate for pulsus).
— POCUS for RA/RV collapse (see chunk 5).
— IV access × 2, gentle IV fluid bolus (250–500 mL NS) can temporize while preparing for drainage.
Step 3 management: In suspected tamponade, avoid intubation/positive-pressure ventilation before drainage if at all possible — increased intrathoracic pressure further reduces venous return and can precipitate PEA arrest. If intubation is unavoidable, have pericardiocentesis equipment at bedside and use ketamine/etomidate with pressors ready.
— Low voltage (QRS <5 mm limb leads, <10 mm precordial) — fluid attenuates signal.
— Electrical alternans — beat-to-beat variation in QRS amplitude from heart swinging in fluid; specific but insensitive, classic with large malignant effusions.
— Diffuse PR depression and concave ST elevation if underlying acute pericarditis.
— Sinus tachycardia, occasionally PEA if arresting.
— Cardiac silhouette enlarged only when effusion ≥200–250 mL.
— "Water-bottle" globular heart, clear lung fields (helps distinguish from CHF).
— Epicardial fat pad sign on lateral view.
— Look for widened mediastinum (dissection) or pulmonary mass (malignancy).
— CBC (leukocytosis → infection; anemia → malignancy/uremia).
— BMP (uremia, hyperkalemia, AKI).
— Troponin (myopericarditis, MI with rupture).
— Coags/INR (anticoagulation reversal needed before drainage).
— Type and screen — especially if dissection or trauma suspected.
— TSH if etiology unclear (myxedema effusions can be huge but tamponade rare).
— HIV, blood cultures if febrile or purulent suspected.
— Pregnancy test (women of reproductive age).
— Confirms presence, size, location, and tamponade physiology.
— Done in parasternal long, subxiphoid, apical 4-chamber views.
CCS pearl: In your CCS case, the order set for suspected tamponade should include — IV access × 2, continuous monitoring, stat bedside echocardiogram, ECG, CXR, CBC, BMP, troponin, coags, type and screen, cardiology consult, and NPO. Avoid scheduling formal echo lab study if patient is unstable; the bedside POCUS satisfies the diagnostic order.
— Effusion size: small <10 mm, moderate 10–20 mm, large >20 mm (end-diastolic, posterior).
— Circumferential vs loculated — post-surgical effusions are often loculated and require surgical drainage.
— RA systolic collapse lasting >⅓ of systole — most sensitive sign.
— RV diastolic collapse — most specific sign.
— Plethoric IVC (>2.1 cm) with <50% inspiratory collapse — elevated RA pressure.
— Respiratory variation in mitral/tricuspid inflow Doppler: >25% decrease in mitral E-wave with inspiration, >40% increase in tricuspid E-wave — echo equivalent of pulsus paradoxus.
— Septal "bounce" with respiration (ventricular interdependence).
— Loculated post-op effusion may compress only LA or LV — high suspicion needed.
— LV hypertrophy or pulmonary hypertension can blunt RV collapse → false negative.
— Severe hypovolemia can produce RA/RV collapse without true tamponade.
— Cardiac CT/MRI: characterize loculations, pericardial thickening (constriction overlap), masses, dissection.
— CT chest with contrast if aortic dissection suspected (and percutaneous drainage contraindicated — needs OR).
— Cell count, gram stain, culture, AFB, cytology, glucose, protein, LDH, ADA (TB), triglycerides (chylopericardium).
— Light's criteria do not apply well; cytology yield ~75% for malignant effusion.
Board pearl: A patient with chronic kidney disease on dialysis with a new pericardial effusion has uremic pericarditis until proven otherwise — treatment is intensified hemodialysis, not steroids or NSAIDs (NSAIDs harm residual renal function), with drainage reserved for tamponade or persistent effusion despite optimized HD.
— Therapeutic: tamponade physiology present → drain.
— Diagnostic: unexplained moderate-to-large effusion, suspected purulent or malignant → drain for fluid analysis.
— Neither: small/moderate asymptomatic effusion with known cause → treat underlying disease, serial echo.
— Clinical tamponade (hypotension, shock, pulsus >10).
— Echocardiographic tamponade with hemodynamic compromise.
— Suspected purulent pericarditis (diagnostic + therapeutic).
— Large effusion (>20 mm) regardless of symptoms, per ESC triage score ≥6 (size, hemodynamics, etiology).
— Aortic dissection with hemopericardium — drainage can precipitate fatal rebleed.
— Post-MI free wall rupture — needs surgical repair; only temporize with small-volume drainage if arresting.
— Traumatic hemopericardium with ongoing bleeding — ED thoracotomy or OR.
— Loculated posterior effusion inaccessible from subxiphoid/apical windows — surgical pericardial window.
— Severe uncorrected coagulopathy (relative — reverse first if possible).
— Score ≥6 → drainage indicated.
— Score <6 → conservative management with serial imaging.
— Small idiopathic/viral effusions without tamponade — NSAIDs + colchicine.
— Effusions from treatable systemic disease (hypothyroidism — levothyroxine; uremia — dialysis).
Step 3 management: When you see "hypotensive patient with new murmur of MR and pulmonary edema 5 days post-MI" — that's free wall rupture or pseudoaneurysm, not routine tamponade. Stat cardiothoracic surgery consult, do not send to cath lab for pericardiocentesis as the first move; bridge with fluids/pressors and rush to OR.
— IV fluids: 250–500 mL crystalloid bolus to augment preload; overuse can worsen RV dilation, so titrate.
— Vasopressors: norepinephrine first-line for hypotension; avoid pure vasoconstrictors that drop CO. Dobutamine can support contractility but may worsen tachycardia.
— Avoid: beta-blockers, diuretics, nitrates, and any preload-reducing agent until effusion drained.
— Acute idiopathic/viral pericarditis with effusion:
— NSAIDs: ibuprofen 600–800 mg PO TID × 1–2 weeks, then taper. ASA 750–1000 mg TID preferred post-MI (Dressler) or with concurrent CAD.
— Colchicine 0.5 mg BID (≥70 kg) or 0.5 mg daily (<70 kg) × 3 months — reduces recurrence by ~50%. Adjust for renal/hepatic impairment, watch for drug interactions (statins, macrolides).
— PPI for GI protection with NSAIDs.
— Avoid steroids as first-line — increase recurrence risk; reserve for NSAID failure, contraindication, or autoimmune etiology, at low-dose prednisone 0.2–0.5 mg/kg with slow taper.
— Bacterial/purulent: broad-spectrum IV antibiotics (vancomycin + ceftriaxone) + urgent drainage + surgical washout.
— TB pericarditis: RIPE therapy × 6 months + adjunctive prednisone (controversial, often used in HIV-negative).
— Uremic: intensify dialysis (daily HD × 5–7 days); avoid systemic anticoagulation during HD.
— Malignant: drainage + intrapericardial sclerosant (bleomycin) or balloon pericardiotomy; systemic chemo per primary tumor.
— Autoimmune (SLE): NSAIDs, colchicine, hydroxychloroquine, prednisone for severe.
— Hypothyroid (myxedema): levothyroxine; effusion resolves over weeks–months without drainage unless tamponade.
Board pearl: Never give diuretics for pericardial effusion — the apparent "fluid overload" picture is actually impaired filling, and reducing preload precipitates shock. This is a classic Step 3 distractor.
— Preferred approach: apical or left parasternal under direct ultrasound guidance (modern standard), or subxiphoid (traditional, blind landmark approach if no US available).
— Patient positioned at 30–45° head-up to pool fluid anteriorly/inferiorly.
— Local anesthesia, sterile prep; 18-gauge needle directed at pocket of largest fluid depth, anterior to vital structures.
— Confirm intrapericardial position with agitated saline contrast ("bubble study") or pressure waveform.
— Place pigtail catheter via Seldinger technique; leave to gravity/low suction drainage until output <25–50 mL/24 h, then remove (typically 1–3 days).
— Remove only enough to relieve tamponade physiology initially (often 50–200 mL produces dramatic hemodynamic improvement).
— Rapid full evacuation of very large effusions can cause pericardial decompression syndrome — acute pulmonary edema and ventricular dysfunction from sudden RV/LV recoil. Drain slowly, in 500 mL aliquots with reassessment.
— RV/RA puncture, coronary laceration, pneumothorax, hemothorax, hepatic injury, arrhythmias, infection, pericardial decompression syndrome, vasovagal.
— Echo guidance reduces complications by ~50% vs blind subxiphoid.
— Loculated/posterior effusions inaccessible percutaneously.
— Hemopericardium from dissection, rupture, trauma.
— Recurrent effusions (especially malignant) → pericardial window (subxiphoid or VATS).
— Purulent pericarditis (often needs surgical washout).
— Constrictive pericarditis or effusive-constrictive → pericardiectomy.
CCS pearl: Orders during/after pericardiocentesis — "pericardiocentesis, echo-guided," "place pericardial drain," "send pericardial fluid for cell count, gram stain, culture, AFB, cytology, glucose, protein, LDH," "post-procedure CXR," "telemetry monitoring," "repeat echo in 24 hours."
— Higher rates of malignant and idiopathic effusions; lower threshold for symptoms to be attributed to "heart failure" → delayed diagnosis.
— More likely on anticoagulants (afib, mechanical valves) → reverse before drainage:
— Warfarin: vitamin K + 4-factor PCC if INR elevated and urgent procedure.
— DOACs: andexanet alfa (apixaban/rivaroxaban) or idarucizumab (dabigatran); PCC if specific reversal unavailable.
— Hold antiplatelet agents when feasible; do not delay life-saving drainage.
— Frailty assessment important for goals-of-care discussions (especially malignant effusion — median survival 2–4 months).
— NSAIDs are relatively contraindicated for pericarditis in elderly with CKD, CHF, or CAD; consider colchicine monotherapy or low-dose prednisone.
— Uremic pericarditis: BUN typically >60; treat with intensified HD (daily × 5–7 days) without systemic heparin (use citrate or regional anticoagulation).
— Dialysis-associated pericarditis: occurs in adequately dialyzed patients — same intensification strategy.
— Effusion >250 mL or tamponade → drainage in addition to HD.
— Colchicine: avoid if CrCl <30 mL/min or on dialysis; dose-reduce if CrCl 30–50.
— NSAIDs: avoid in CKD stages 3–5; harms residual renal function and dialysis access.
— Contrast CT: weigh benefit; cardiac MRI alternative if eGFR very low (avoid gadolinium <30).
— Cirrhotic patients may develop effusion from hypoalbuminemia or polyserositis — usually small, no drainage needed.
— Coagulopathy (INR↑, thrombocytopenia) requires correction (FFP, platelets, vitamin K) before elective drainage.
— NSAIDs increase variceal bleeding and AKI risk — avoid.
— Colchicine hepatically metabolized — reduce dose in Child-Pugh B/C.
Key distinction: "Uremic pericarditis" (pre-dialysis or under-dialyzed) vs "dialysis-associated pericarditis" (adequately dialyzed) — both respond to dialysis intensification, but the latter raises concern for missed sessions, inadequate clearance, or alternative etiology (viral, autoimmune) — work up accordingly.
— Small, asymptomatic effusions occur in up to 40% of third-trimester pregnancies — physiologic, resolve postpartum, no intervention.
— Tamponade is rare; causes include peripartum cardiomyopathy with effusion, aortic dissection (especially Marfan, bicuspid valve), and autoimmune (SLE flare).
— NSAIDs: avoid after 20 weeks (oligohydramnios, premature ductus closure) and absolutely after 30 weeks.
— Colchicine: generally considered safe in pregnancy (extensive FMF data); preferred anti-inflammatory.
— Aspirin low-dose acceptable; high-dose avoid in third trimester.
— Prednisone low-dose acceptable if needed.
— Pericardiocentesis safe in pregnancy with shielding; echo guidance avoids fluoroscopy.
— Aortic dissection in pregnancy → emergent surgical management; high maternal/fetal mortality.
— Most common causes: viral (coxsackie, adenovirus, COVID-19), post-viral idiopathic, post-cardiac surgery, rheumatologic (JIA, SLE), malignancy (lymphoma, leukemia).
— Purulent pericarditis (staph, strep, H. influenzae) more common than adults — needs urgent drainage + IV antibiotics.
— MIS-C (post-COVID) can present with pericardial effusion and myocarditis.
— Ibuprofen + colchicine first-line for pericarditis; weight-based dosing.
— Pericardiocentesis under general anesthesia/sedation with echo guidance.
— Broaden differential: TB, fungal (histoplasma, cryptococcus), CMV, Kaposi sarcoma, lymphoma.
— Lower threshold for diagnostic drainage with full microbiology panel including AFB, fungal cultures, ADA.
— TB pericarditis: leading cause of pericardial disease in HIV-endemic regions; high mortality without treatment.
Board pearl: A young woman with malar rash, arthralgias, pleural and pericardial effusions — think SLE serositis. Order ANA, anti-dsDNA, anti-Smith, complement (C3/C4 low in active disease), urinalysis. Treat with NSAIDs/colchicine for mild, hydroxychloroquine baseline, prednisone for moderate-severe.
— PEA arrest within minutes to hours of decompensation.
— Multiorgan hypoperfusion: AKI, hepatic injury, lactic acidosis, mesenteric ischemia.
— Mortality near 100% if not drained.
— Cardiac chamber laceration (most often RV) → hemopericardium, may require emergent surgical repair.
— Coronary artery laceration (LAD, RCA) → MI, hemopericardium.
— Pneumothorax/hemothorax — apical and parasternal approaches at higher risk.
— Hepatic laceration — subxiphoid blind approach.
— Arrhythmias — PVCs, VT, transient AV block from epicardial irritation.
— Vasovagal reaction, bradycardia, hypotension.
— Pericardial decompression syndrome (1–5%): paradoxical hemodynamic deterioration and pulmonary edema after rapid fluid removal; prevented by staged drainage.
— Infection of pericardial space from prolonged drain.
— Recurrent effusion — especially malignant (50–70% recur within weeks); requires pericardial window, sclerosis, or pericardiectomy.
— Constrictive pericarditis — fibrosis of pericardium causing diastolic dysfunction; presents weeks–months later with right heart failure signs, Kussmaul, pericardial knock.
— Effusive-constrictive pericarditis — persistent elevated RA pressure after drainage of effusion; constriction physiology of visceral pericardium.
— Dressler syndrome recurrence if post-MI etiology.
— Malignant: short median survival (2–4 months in lung cancer; longer in breast/lymphoma).
— TB: 30–50% develop constriction even with adequate therapy.
— Purulent: high mortality (~40%) and constriction risk.
Step 3 management: New onset right-sided heart failure, Kussmaul sign, pericardial knock, and "square root sign" on cath weeks after pericarditis or tamponade drainage — that's constrictive pericarditis. Definitive treatment is pericardiectomy; medical therapy (diuretics) is only palliative.
— Confirmed tamponade pre- or post-drainage.
— Hemodynamic instability requiring vasopressors.
— Purulent pericarditis (sepsis risk).
— Post-procedure pericardial drain in place.
— Anticoagulation reversal in progress.
— Concurrent myocarditis with ventricular dysfunction.
— Cardiology: all moderate-to-large effusions, all tamponade, all pericarditis with effusion. Guides drainage decision and follow-up.
— Cardiothoracic surgery: post-MI rupture, aortic dissection, traumatic hemopericardium, loculated post-op effusion, recurrent malignant effusion requiring window, suspected constriction.
— Interventional cardiology: catheter-based drainage and complex cases.
— Oncology: malignant effusion management, sclerosis, systemic therapy planning.
— Infectious disease: purulent, TB, fungal, immunocompromised hosts.
— Nephrology: uremic etiology for HD intensification.
— Rheumatology: autoimmune workup.
— Hemodynamically stable patients post-drainage with drain removed and confirmed resolution.
— Moderate idiopathic/viral effusion without tamponade, started on NSAIDs/colchicine.
— Small idiopathic effusion + acute pericarditis with low-risk features: no fever, no leukocytosis, no large effusion, no troponin elevation, responsive to NSAIDs, no immunosuppression, no anticoagulation.
— Outpatient cardiology follow-up within 1 week, repeat echo in 1–2 weeks.
— Fever >38°C, subacute onset, large effusion (>20 mm), tamponade, NSAID failure after 1 week, myopericarditis (troponin↑), immunosuppression, trauma, oral anticoagulation.
CCS pearl: When advancing the clock on a stable post-pericardiocentesis patient, order — "transfer to CCU/telemetry," "vital signs q4h," "repeat echocardiogram in 24 hours," "remove pericardial drain when output <25 mL/24 h," "continue colchicine and ibuprofen," "cardiology follow-up in 1 week."
— Sharp pleuritic chest pain, worse supine, relieved sitting forward; friction rub; diffuse ST elevation, PR depression; normal echo or small effusion.
— Treatment: NSAIDs + colchicine; no drainage.
— Troponin elevation predominates; ventricular dysfunction on echo; cardiac MRI shows LGE.
— Restrict exercise × 3–6 months; avoid NSAIDs early in myocarditis (animal data suggest harm); supportive care.
— Right heart failure, Kussmaul sign, pericardial knock, square-root/dip-and-plateau on cath.
— Echo: septal bounce, respiratory mitral inflow variation, dilated IVC, annulus reversus (medial e' > lateral e').
— CT/MRI: pericardial thickening >4 mm, calcification.
— Treatment: pericardiectomy.
— Persistent elevation of RA pressure after pericardiocentesis lowers intrapericardial pressure to zero.
— Combined visceral pericardial constriction + fluid; may need visceral pericardiectomy.
— Incidental on imaging; congenital cyst at right cardiophrenic angle; primary tumors rare (mesothelioma).
— Metastases (lung, breast, lymphoma, melanoma) far more common.
— Trauma, post-surgery, or fistula from esophagus/stomach.
— "Halo" sign on CXR; treat underlying cause.
Key distinction: Constriction vs restriction — both cause right heart failure with preserved EF. Constriction has respiratory variation in mitral inflow (>25%), annulus reversus (preserved or augmented septal e'), and pericardial thickening; restriction has no respiratory variation, reduced septal e', and biatrial enlargement. Constriction is surgically curable; restriction often is not.
— Acute dyspnea, hypotension, elevated JVP, clear lungs, sinus tachycardia — overlaps heavily with tamponade.
— RV strain on ECG (S1Q3T3), elevated D-dimer, RV dilation on echo without effusion, McConnell sign (apex-sparing RV free wall hypokinesis).
— CT pulmonary angiogram diagnostic; treat with anticoagulation ± thrombolysis.
— Inferior MI with RV involvement; hypotension with clear lungs, elevated JVP, Kussmaul.
— ECG: ST elevation in V4R; right-sided leads diagnostic.
— Treatment: aggressive IV fluids, avoid nitrates/morphine/diuretics, urgent reperfusion.
— Trauma or barotrauma; hypotension, tracheal deviation, absent breath sounds, hyperresonance on affected side.
— Bedside diagnosis → needle decompression then chest tube; do not wait for CXR.
— Pulmonary edema, S3, rales — distinguishes from tamponade (clear lungs).
— Echo shows depressed EF, often without significant effusion.
— Warm extremities (early), fever, source identifiable; lactate elevated.
— Echo without tamponade physiology.
— Type A dissection rupturing into pericardium — both diagnoses simultaneously.
— Sharp tearing chest/back pain, BP differential between arms, mediastinal widening.
— Do not percutaneously drain — emergent cardiothoracic surgery; only controlled small-volume drainage if peri-arrest.
— Can produce pulsus paradoxus and dyspnea but with wheezing, hyperresonance, and normal cardiac silhouette.
Board pearl: Hypotension + clear lungs + elevated JVP triad differential is short — tamponade, RV infarct, massive PE, tension pneumothorax. Bedside ultrasound (cardiac + lung) distinguishes all four within minutes.
— Colchicine × 3 months reduces recurrence from ~30% to ~15% (CORP, ICAP trials) — single most important long-term intervention.
— Taper NSAIDs over 2–4 weeks based on symptom resolution and CRP normalization.
— Recurrent pericarditis (≥1 episode after symptom-free interval ≥4–6 weeks): extend colchicine to 6 months, consider IL-1 blocker (anakinra, rilonacept — FDA-approved for recurrent pericarditis) for steroid-dependent or refractory cases.
— Activity restriction: avoid strenuous exercise until symptoms resolved and CRP/echo normal (≥3 months for athletes with myopericarditis).
— Pericardial window or indwelling catheter for recurrent drainage.
— Systemic chemotherapy/immunotherapy directed at primary tumor.
— Goals-of-care discussion — median survival often months; palliative care referral.
— Optimize dialysis adequacy (Kt/V target), daily HD until resolution.
— Address vascular access, missed sessions, dietary nonadherence.
— Complete 6-month RIPE regimen with DOT.
— Screen contacts, report to public health.
— Monitor for development of constriction → surgical evaluation.
— Disease-specific therapy (hydroxychloroquine for SLE, methotrexate for RA).
— Long-term rheumatology follow-up.
— ASA preferred (continues secondary prevention) + colchicine.
— Avoid full-dose NSAIDs and steroids early post-MI (impair healing, increase rupture risk).
— Hold anticoagulation during acute pericarditis with effusion if possible; resume cautiously after effusion resolution.
Step 3 management: A patient with second episode of pericarditis 3 months after initial viral pericarditis — diagnosis is recurrent pericarditis. First-line is NSAIDs + colchicine ≥6 months; reserve steroids for failure/contraindication; refer for IL-1 blocker if steroid-dependent or multiply recurrent.
— Cardiology clinic at 1 week after acute pericarditis/effusion discharge.
— Repeat TTE at 1 week if moderate effusion, then 1 month, 3 months, 6 months until resolution.
— CRP at each visit — guides duration of anti-inflammatory therapy (continue until CRP normalizes).
— Primary care visit at 2 weeks for medication review and adherence.
— NSAID therapy: CBC, renal function, BP at 2 weeks; assess GI symptoms.
— Colchicine: CBC and LFTs at 1 month and 3 months; watch for diarrhea, myopathy, neuropathy; avoid grapefruit, CYP3A4 inhibitors.
— Steroids: glucose, BP, bone density (DEXA if >3 months use), calcium/vitamin D supplementation, PPI for GI prophylaxis, PJP prophylaxis if ≥20 mg prednisone × ≥4 weeks.
— IL-1 blockers: infection screening, neutrophil count.
— Return precautions: recurrent chest pain, worsening dyspnea, syncope, fever, leg swelling — return immediately.
— Activity restriction: avoid competitive sports and vigorous exercise until cleared by cardiology (≥3 months for myopericarditis, until symptom resolution and normal echo/CRP for pericarditis).
— Vaccination: influenza, COVID-19, pneumococcal — especially if on immunosuppression.
— Medication adherence: emphasize colchicine completion (3 months for first episode, 6 months for recurrence) prevents recurrence.
— Lifestyle: alcohol moderation (colchicine interaction, NSAID GI risk), avoid NSAIDs/anticoagulants beyond prescribed.
— Trigger avoidance: identify and avoid known precipitants (viral exposure, missed dialysis, dietary indiscretion in CKD).
CCS pearl: Discharge orders for post-pericarditis patient — "ibuprofen 600 mg PO TID × 2 weeks then taper," "colchicine 0.6 mg PO BID × 3 months," "omeprazole 20 mg daily," "cardiology follow-up 1 week," "repeat echo 1 week," "CRP at follow-up," "activity restriction," "return precautions."
— Standard: explain risks (cardiac/coronary laceration, pneumothorax, arrhythmia, infection, death ~1%), benefits, alternatives (surgical window, watchful waiting if no tamponade).
— Emergency exception: in unconscious or peri-arrest patient with tamponade, implied consent doctrine applies — proceed without delay; document clinical urgency and attempts to reach surrogate.
— Decisional-capacity assessment if patient declines: ensure understanding of imminent death without intervention; psychiatric involvement only if capacity unclear, not as a means to override refusal.
— Jehovah's Witness considerations: pericardiocentesis itself is not a blood product issue, but discuss blood-product preferences in case of complication requiring transfusion; document advance directives.
— Malignant tamponade in patient with advanced cancer — discuss whether drainage aligns with patient's goals; some prefer comfort-focused management.
— Pericardial window vs indwelling catheter vs no intervention is a values-based decision.
— Involve palliative care early; clarify code status before procedure.
— Traumatic hemopericardium from suspected assault, gunshot, stabbing → law enforcement reporting per state law.
— Suspected intimate partner violence or child abuse causing trauma → social work and mandated reporter pathways.
— TB pericarditis → reportable to public health department.
— High-risk handoff after pericardiocentesis — ensure receiving team knows drain status, pressor needs, anticoagulation hold/resume plan, follow-up echo timing.
— Discharge medication reconciliation critical: confirm colchicine duration, NSAID taper, PPI, and that previously held anticoagulants are either resumed with plan or remain held with documented reasoning.
— Closed-loop communication to outpatient cardiologist and PCP — written summary with pending pathology (cytology, AFB cultures).
Board pearl: A patient with metastatic lung cancer and tamponade who has clearly documented DNR/DNI but no specific directive on pericardiocentesis — drainage is not equivalent to resuscitation; clarify goals with patient/family before assuming DNR precludes intervention. Many patients accept drainage as comfort measure.
Key distinction: "Absent y descent" = tamponade; "Prominent y descent (Friedreich sign)" = constriction. Both have elevated JVP, but the waveform tells the story.
Step 3 management: When a CCS case presents with hypotension + JVP elevation + clear lungs, immediate orders should be bedside echo, IV fluids, two large-bore IVs, cardiology consult, and prepare for pericardiocentesis — do not order diuretics, nitrates, or beta-blockers reflexively.
Pericardial tamponade is a clinical-echocardiographic diagnosis defined by hemodynamic compromise from intrapericardial pressure exceeding cardiac chamber filling pressures, treated with urgent echo-guided pericardiocentesis — except when the etiology is aortic dissection, post-MI free wall rupture, or traumatic hemopericardium, which require emergent surgical management.
Board pearl: If you remember only one thing — clear lungs + shock + elevated JVP = tamponade, RV infarct, PE, or tension pneumothorax; bedside echo answers the question in under five minutes and dictates whether the next step is a needle, a chest tube, anticoagulation, or the OR.